• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素 Visfatin 在糖脂病及其相关代谢紊乱发病机制中的作用。

Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.

机构信息

School of Life Sciences, Central University of Gujarat, Sector 30, Gandhinagar - 382030, Gujarat, India.

出版信息

Curr Mol Med. 2018;18(2):116-125. doi: 10.2174/1566524018666180705114131.

DOI:10.2174/1566524018666180705114131
PMID:29974830
Abstract

Visfatin is one of the prominent adipokines secreted by adipose tissue. The level of visfatin increases significantly in persons with obesity owing to increased body mass index (BMI). During obesity, the adipocytes, which populate adipose tissue, undergo hypertrophy and hyperplasia and secrete a number of adipocytokines including visfatin. Visfatin, which also acts as an enzyme nicotinamide phosphoribosyl transferase, is one of the prominent adipokines that influence metabolic homeostasis in the body. Visfatin exists in two forms, extracellular and intracellular, and enacts a multitude of actions. The direct and indirect evidence gathered from in-vitro, in-vivo and clinical studies indicate that visfatin modulates obesity and metabolic syndrome-related pathophysiological activities including enhanced inflammation, angiogenesis, synthesis of NAD mononucleotide, and upregulation of antiapoptotic proteins in a number of cell types. It has been implicated in a number of obesity-related alterations and metabolic derangement such as diabetes, cardiovascular complications and some forms of cancers. In this review, the novel hypothesis about the role of visfatin in diabesity has been proposed which implies recent advances in studies about the pathophysiological roles of visfatin during obesity and chronic high glucose in the circulation. Visfatin at high concentration attracts immune cells and produces chronic inflammation in adipocytes. Additionally, it induces insulin resistance in many tissues and causes pancreatic beta cells dysfunction at later stages. Further, its potential as an important target to develop molecular medicine in diabesity and related metabolic syndrome has been highlighted.

摘要

内脂素是脂肪组织分泌的主要脂肪因子之一。由于体重指数(BMI)增加,肥胖人群的内脂素水平显著升高。在肥胖期间,填充脂肪组织的脂肪细胞发生肥大和增生,并分泌包括内脂素在内的多种脂肪细胞因子。内脂素还作为烟酰胺磷酸核糖基转移酶发挥作用,是影响体内代谢平衡的主要脂肪因子之一。内脂素有细胞外和细胞内两种形式,发挥多种作用。来自体外、体内和临床研究的直接和间接证据表明,内脂素调节肥胖和代谢综合征相关的病理生理活动,包括增强炎症、血管生成、NAD 单核苷酸的合成以及多种细胞类型中抗凋亡蛋白的上调。它与许多肥胖相关的改变和代谢紊乱有关,如糖尿病、心血管并发症和某些形式的癌症。在这篇综述中,提出了内脂素在糖尿病肥胖中的作用的新假说,这暗示了在肥胖和循环中慢性高葡萄糖期间内脂素的病理生理作用的研究的最新进展。高浓度的内脂素吸引免疫细胞并在脂肪细胞中产生慢性炎症。此外,它在许多组织中诱导胰岛素抵抗,并在后期导致胰腺β细胞功能障碍。进一步强调了其作为开发糖尿病肥胖和相关代谢综合征的分子医学的重要靶点的潜力。

相似文献

1
Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.脂联素 Visfatin 在糖脂病及其相关代谢紊乱发病机制中的作用。
Curr Mol Med. 2018;18(2):116-125. doi: 10.2174/1566524018666180705114131.
2
Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.内脏脂肪素受罗格列酮调节并受 NFκB 和 JNK 影响在人类腹部皮下脂肪细胞中 2 型糖尿病。
PLoS One. 2011;6(6):e20287. doi: 10.1371/journal.pone.0020287. Epub 2011 Jun 9.
3
Cardiotrophin-1 Regulates Adipokine Production in 3T3-L1 Adipocytes and Adipose Tissue From Obese Mice.心肌营养素-1调节3T3-L1脂肪细胞和肥胖小鼠脂肪组织中脂肪因子的产生。
J Cell Physiol. 2017 Sep;232(9):2469-2477. doi: 10.1002/jcp.25590. Epub 2017 Apr 10.
4
Visfatin/Nampt: an adipokine with cardiovascular impact.内脏脂肪素/Nampt:具有心血管影响的脂肪因子。
Mediators Inflamm. 2013;2013:946427. doi: 10.1155/2013/946427. Epub 2013 Jun 16.
5
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.内脂素:一种由内脏脂肪分泌的蛋白质,可模拟胰岛素的作用。
Science. 2005 Jan 21;307(5708):426-30. doi: 10.1126/science.1097243. Epub 2004 Dec 16.
6
[The role of visfatin in the pathophysiology of human].内脂素在人类病理生理学中的作用
Wiad Lek. 2009;62(3):190-6.
7
The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.内脏脂肪细胞分泌活性分子在腹型肥胖及其相关心血管疾病发生发展中的作用:综述
Biomolecules. 2020 Feb 28;10(3):374. doi: 10.3390/biom10030374.
8
Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis.瘦素与脂肪细胞因子:弥合免疫与动脉粥样硬化之间的差距
Curr Pharm Des. 2007;13(36):3676-80. doi: 10.2174/138161207783018635.
9
Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?PBEF/内脂素/烟酰胺磷酸核糖转移酶是一种与代谢综合征相关的真正脂肪因子吗?
Curr Hypertens Rep. 2007 Mar;9(1):33-8. doi: 10.1007/s11906-007-0007-5.
10
CTRP3 modulates the expression and secretion of adipokines in 3T3-L1 adipocytes.CTRP3调节3T3-L1脂肪细胞中脂肪因子的表达和分泌。
Endocr J. 2014;61(12):1153-62. doi: 10.1507/endocrj.EJ14-0161. Epub 2014 Aug 27.

引用本文的文献

1
Adipokines in preeclampsia: disrupted signaling pathways and novel therapeutic strategies.子痫前期中的脂肪因子:信号通路紊乱与新型治疗策略
Eur J Med Res. 2025 Aug 4;30(1):702. doi: 10.1186/s40001-025-02972-y.
2
Selective remodelling of the adipose niche in obesity and weight loss.肥胖与体重减轻过程中脂肪微环境的选择性重塑
Nature. 2025 Jul 9. doi: 10.1038/s41586-025-09233-2.
3
High Serum Levels of Irisin, Visfatin and Adiponectin as Potential Independent Risk Factors for Diabetic Nephropathy Progression in Patients With Type 2 Diabetes Mellitus.
血清鸢尾素、内脂素和脂联素水平升高作为2型糖尿病患者糖尿病肾病进展的潜在独立危险因素
In Vivo. 2025 May-Jun;39(3):1615-1624. doi: 10.21873/invivo.13962.
4
Relationship of visfatin with obesity and osteoporosis in patients with inflammatory bowel disease: a narrative review.内脏脂肪素与炎症性肠病患者肥胖及骨质疏松症的关系:一篇叙述性综述
Front Immunol. 2025 Mar 18;16:1533955. doi: 10.3389/fimmu.2025.1533955. eCollection 2025.
5
Visfatin Enhances RANKL-Induced Osteoclastogenesis In Vitro: Synergistic Interactions and Its Role as a Mediator in Osteoclast Differentiation and Activation.内脂素在体外增强RANKL诱导的破骨细胞生成:协同相互作用及其在破骨细胞分化和激活中的介导作用
Biomolecules. 2024 Nov 25;14(12):1500. doi: 10.3390/biom14121500.
6
The dual challenge of diabesity: pathophysiology, management, and future directions.糖尿病性肥胖的双重挑战:病理生理学、管理及未来方向。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4891-4912. doi: 10.1007/s00210-024-03713-4. Epub 2024 Dec 16.
7
Adipokines and their role in acute pancreatitis.脂肪细胞因子及其在急性胰腺炎中的作用。
J Med Biochem. 2024 Jun 15;43(4):512-527. doi: 10.5937/jomb0-47515.
8
Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides.地中海饮食对血管健康和血清脂联素及神经酰胺水平的影响。
PLoS One. 2024 May 29;19(5):e0300844. doi: 10.1371/journal.pone.0300844. eCollection 2024.
9
Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers.脂肪肿瘤学:脂肪细胞衍生因子控制转移性癌症的植入、存活和进展。
Cell Commun Signal. 2024 Jan 18;22(1):52. doi: 10.1186/s12964-024-01474-4.
10
Fibroblast growth factor-21 and Visfatin as potential predictors for metabolic risk factors in obese children.成纤维细胞生长因子 21 和内脂素作为肥胖儿童代谢危险因素的潜在预测因子。
Sci Rep. 2024 Jan 12;14(1):1190. doi: 10.1038/s41598-024-51394-z.